For Institute program-specific acronyms, go to NIAID Profile and Fact Book.
National Advisory Allergy and Infectious Diseases Council. Also see Council, advisory.
Three subcommittees of the National Advisory Allergy and Infectious Diseases Council, which conduct second-level review and advise the NIAID's extramural program divisions—DAIDS, DMID, and DAIT—to which they correspond.
Go to NIAID's Advisory Council portal.
NIAID's main advisory Council. Also see dual peer review. Go to NIAID's Advisory Council portal.
NIH institute that conducts and supports research to understand, treat, and prevent infectious, immunologic, and allergic diseases. Go to NIAID.
Federal government agency that conducts and supports biomedical and behavioral research to create fundamental knowledge of living systems and reduce the burden of illness and disability.
Go to NIH and NIAID's NIH Organization and Process questions and answers.
World's largest medical library, with information and research services in biomedicine and health care. Find resources such as PubMed and NCBI. Go to NLM.
Programs for training grants and fellowships.
Go to these resources:
Body that advises federal agencies on ways to minimize the possibility that biological research knowledge and technologies will be used to threaten public health or national security.
Go to National Science Advisory Board for Biosecurity and NIAID's Biodefense and Select Agents portal.
Program that maintains a comprehensive list of select agents and related information for investigators who possess, use, or transfer select agents in the U.S.
CDC in HHS and Animal and Plant Health Inspection Service (APHIS) in USDA administer the program. See overlap select agent.
Human subjects term indicating a person having origins in the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands.
NIH policy requires this minority group to be included in clinical research barring a compelling rationale not to do so. See Planned Enrollment Report and Cumulative Inclusion Enrollment Report.
Five-character code that identifies foreign organizations conducting business with the U.S. federal government. Foreign organizations must obtain an NCAGE before registering with the System for Award Management (SAM).
Go to the Department of Defense's Commercial and Government Entity and How to Obtain a NATO CAGE Code
See NATO Commercial and Government Entity code.
National Center for Complementary and Alternative Medicine. Go to NCCAM.
National Center for Advancing Translational Sciences. Go to NCATS.
National Cancer Institute. Go to NCI.
National Center for Research Resources.
NIH dissolved NCRR as part of the FY 2012 Omnibus Appropriations bill and transferred its programs to other institutes and centers (IC), such as NCATS, NIGMS, and NIMHD.
See New Drug Application.
Contracting method using proposals and discussions. A contract awarded without using sealed bidding procedures is a negotiated contract.
National Eye Institute. Go to NEI.
Grant application that NIH has not previously funded; also called a type 1. Also see renewal and noncompeting.
Application by a drug sponsor to FDA to approve a new pharmaceutical for sale and marketing in the U.S. under regulations 21 CFR 314, based on data from animal studies and clinical trials. See investigational new drug application.
Go to 21 CFR 314.
Scientist who has never successfully competed as a principal investigator on many types of NIH grants, including an R01. Investigators who are appointed as PI for an existing grant still qualify as new. See early-stage investigator.
Go to these resources:
Notice of Grant Award, formerly used term. See Notice of Award.
National Human Genome Research Institute. Go to NHGRI.
National Heart, Lung, and Blood Institute. Go to NHLBI.
National Institute on Aging. Go to NIA.
National Institute on Alcohol Abuse and Alcoholism. Go to NIAAA.
See National Institute of Allergy and Infectious Diseases.
SBIR award NIAID uses to fund projects that have progressed significantly along the pathway to FDA approval (or foreign equivalent).
STTR award NIAID uses to fund projects that have progressed significantly along the pathway to FDA approval (or foreign equivalent).
Pathogen on NIAID's list that expands the legislated select agent and overlap select agent lists. NIAID uses its list to fund high-priority biodefense applications. Also see dual use research, highly pathogenic infectious agent, and USA Patriot Act.
Go to these NIAID resources:
Also go to the HHS and USDA Select Agents and Toxins List..
Six major components into which NIAID is divided (in addition to the Office of the Director):
For contact information, go to:
NIAID organization whose offices report directly to the NIAID director. Go to Office of the Director.
National Institute of Arthritis and Musculoskeletal and Skin Diseases. Go to NIAMS.
National Institute for Biomedical Imaging and Bioengineering. Go to NIBIB.
Eunice Kennedy Shriver National Institute of Child Health and Human Development. Go to NICHD.
National Institute on Drug Abuse. Go to NIDA.
National Institute of Deafness and Other Communication Disorders. Go to NIDCD.
National Institute of Dental and Craniofacial Research. Go to NIDCR.
National Institute of Diabetes and Digestive and Kidney Diseases. Go to NIDDK.
National Institute of Environmental Health Sciences. Go to NIEHS.
National Institute of General Medical Sciences. Go to NIGMS.
See National Institutes of Health.
See eRA Commons.
See signing official.
Plan that sets general funding policies for NIH and forms the basis of NIAID's financial management plan.
Document containing NIH policy requirements for grants. Go to NIH Grants Policy Statement.
Weekly NIH publication of policy notices and funding opportunities: program announcements, requests for applications, and some solicitations. Full name is NIH Guide for Grants and Contracts.
Announcement published in the NIH Guide informing the extramural research community of policy changes.
Go to NIH Guide.
National Institute of Mental Health. Go to NIMH.
National Institute on Minority Health and Health Disparities. Go to NIMHD.
National Institute of Neurological Disorders and Stroke. Go to NINDS.
National Institute for Nursing Research. Go to NINR.
See National Library of Medicine.
See Notice of Award.
Extension of a contract's period of performance, requiring a bilateral contract modification.
Extension of a grant's project period without additional funds. For grants issued under expanded authorities, a principal investigator does not need approval from NIAID to extend a project period one time for up to twelve months.
Go to these NIAID resources:
Ongoing grant whose award is contingent on a grantee's submitting a progress report to NIAID.
Also called Type 5; see application type and progress report for grants.
Movement of budget authority from one NIH account to another in a way that does not involve an outlay of government funds.
Volunteer human subject who either does not have the condition being researched or is being studied for normal physiology or behavior.
Describes a grant application that does not receive a full initial peer review or overall impact score because it was either streamlined or not recommended for further consideration.
These applications receive the primary and secondary reviewers' critiques instead of a summary statement. Occasionally, a not discussed application is funded by a special action of an NIH institute's advisory Council. Also see the converse recommended.
Judgment by a scientific review group that a grant application lacks significant and substantial scientific or technical merit or that involves serious hazards or unethical procedures. Such applications do not warrant a review and are not eligible for funding. See also not discussed and the converse recommended.
Legally binding document that notifies a grantee and others that a grant has been funded. It contains or references all terms and conditions of award and documents the obligation of federal funds.
See not recommended for further consideration.
See National Research Service Award.
See National Science Advisory Board for Biosecurity
No in-house study section.
Code of research ethics developed during the trials of Nazi war criminals following World War II and widely adopted as a standard during the 1950s and 1960s for protecting human subjects. See Belmont Report, and go to the Belmont Report.
Last Updated September 30, 2014
Last Reviewed April 26, 2012